Discontinuing an tumor necrosis factor alpha (TNF alpha) blocking agent reactivates the patient's immune system. If the patient has developed an infection then the reconstituted immune system can trigger a system inflammatory reaction termed the immune reconstitution inflammatory syndrome (IRIS).